Sign In
Buy IHE
$101.62
-0.84 (-0.82%)
At Close: Jul 31, 2026
Healthcare & Biotech ETFs Digest GILD's Failure News: 5 Winners
06:30pm, Friday, 24'th Apr 2020
Biotech and healthcare ETFs were pretty stable on Apr 23 despite the news that Gilead's Remdesivir failed to improve Covid-19 patients' condition.
JNJ Beats, Cuts View on Coronavirus: Healthcare ETFs in Focus
02:15pm, Wednesday, 15'th Apr 2020
Investors should closely watch the movement of the stock and keep a close eye on ETFs having double-digit allocation to this diversified drug maker post its earnings release.
JNJ Beats, Cuts View on Coronavirus: Healthcare ETFs in Focus
12:00am, Wednesday, 15'th Apr 2020UBS Group AG Purchases 726 Shares of iShares US Pharmaceuticals ETF (NYSEARCA:IHE)
08:24am, Tuesday, 14'th Apr 2020
UBS Group AG increased its stake in shares of iShares US Pharmaceuticals ETF (NYSEARCA:IHE) by 7.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exch
Bank of America Corp DE Has $5.04 Million Stock Holdings in iShares US Pharmaceuticals ETF (NYSEARCA:IHE)
08:44am, Monday, 13'th Apr 2020
Bank of America Corp DE lifted its stake in shares of iShares US Pharmaceuticals ETF (NYSEARCA:IHE) by 61.4% in the fourth quarter, according to the company in its most recent filing with the SEC. The
Dividend Investors Should Buy Johnson & Johnson Stock On Pullbacks
05:20pm, Thursday, 09'th Apr 2020
Johnson and Johnson's diversified business model will help JNJ stock weather any potential economic slowdown in the rest of the year, so investors can rest easy with the company's consistent dividends
Raymond James & Associates Has $545,000 Stock Position in iShares US Pharmaceuticals ETF (NYSEARCA:IHE)
11:12am, Monday, 06'th Apr 2020
Raymond James & Associates lowered its holdings in shares of iShares US Pharmaceuticals ETF (NYSEARCA:IHE) by 69.7% in the fourth quarter, according to its most recent 13F filing with the SEC. The ins
First Republic Investment Management Inc. Reduces Position in iShares US Pharmaceuticals ETF (NYSEARCA:IHE)
10:04am, Wednesday, 01'st Apr 2020
First Republic Investment Management Inc. cut its position in iShares US Pharmaceuticals ETF (NYSEARCA:IHE) by 2.6% during the fourth quarter, according to the company in its most recent 13F filing wi
Ameritas Investment Company LLC Raises Stock Holdings in iShares US Pharmaceuticals ETF (NYSEARCA:IHE)
08:50am, Saturday, 28'th Mar 2020
Ameritas Investment Company LLC boosted its stake in iShares US Pharmaceuticals ETF (NYSEARCA:IHE) by 21.9% during the 4th quarter, according to the company in its most recent filing with the Securiti
Advisor Group Inc. Sells 244 Shares of iShares US Pharmaceuticals ETF (NYSEARCA:IHE)
08:12am, Saturday, 28'th Mar 2020
Advisor Group Inc. lessened its holdings in shares of iShares US Pharmaceuticals ETF (NYSEARCA:IHE) by 11.2% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owne
iShares US Pharmaceuticals ETF (NYSEARCA:IHE) Shares Bought by Envestnet Asset Management Inc.
08:34am, Monday, 23'rd Mar 2020
Envestnet Asset Management Inc. boosted its stake in shares of iShares US Pharmaceuticals ETF (NYSEARCA:IHE) by 3.0% in the fourth quarter, according to its most recent disclosure with the SEC. The fi
Fmr LLC Raises Holdings in iShares US Pharmaceuticals ETF (NYSEARCA:IHE)
08:36am, Tuesday, 17'th Mar 2020
Fmr LLC boosted its holdings in shares of iShares US Pharmaceuticals ETF (NYSEARCA:IHE) by 57.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?
01:06pm, Thursday, 05'th Mar 2020
Sector ETF report for PPH
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?
12:00am, Thursday, 05'th Mar 2020First Allied Advisory Services Inc. Has $326,000 Stock Position in iShares US Pharmaceuticals ETF (NYSEARCA:IHE)
12:30pm, Sunday, 01'st Mar 2020
First Allied Advisory Services Inc. lowered its stake in shares of iShares US Pharmaceuticals ETF (NYSEARCA:IHE) by 30.1% during the 4th quarter, according to its most recent Form 13F filing with the
